IHAM
CINC

Integral Health Asset Management’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Integral Health Asset Management’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-50,000
Closed -$1.64M – 92
2022
Q3 		$1.64M Buy
50,000
+8,252
+20% +$233K 0.32% 61
2022
Q2 		$787K Buy
+41,748
New +$799K 0.16% 62

Other funds holding CINC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Integral Health Asset Management's CINC Position: Q4 2022 in Review

Integral Health Asset Management sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q4 2022, closing a stake of 50,000 shares — an estimated $1.64M sold.

Integral Health Asset Management first reported a position in CINC in Q2 2022 and held it in 2 quarters. The position peaked at $1.64M in Q3 2022. 102 funds tracked by Wall St. Rank hold CINC as of Q4 2022.

  • Integral Health Asset Management reported no remaining CinCor Pharma, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Integral Health Asset Management sold 50,000 CinCor Pharma, Inc. Common Stock shares in Q4 2022, an estimated $1.64M.
  • Integral Health Asset Management first reported a position in CinCor Pharma, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Integral Health Asset Management's CinCor Pharma, Inc. Common Stock position peaked at $1.64M in Q3 2022.
  • 102 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q4 2022.

Based on Integral Health Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.